investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
Mark Y Chiang
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Tomasz Cierpicki
University of Michigan–Ann Arbor
Ann Arbor, United States
Sunny Wong
University of Michigan–Ann Arbor
Ann Arbor, United States
Rork Kuick
University of Michigan–Ann Arbor
Ann Arbor, United States
Maria Figueroa
University of Michigan–Ann Arbor
Ann Arbor, United States
Linda Samuelson
University of Michigan–Ann Arbor
Ann Arbor, United States
Gregory R Dressler
University of Michigan–Ann Arbor
Ann Arbor, United States
Andrew Weng
BC Cancer Agency
Vancouver, Canada
Mark Y Chiang
University of Michigan–Ann Arbor
Ann Arbor, United States
Related projects
Tait D Shanafelt
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Hematology and hematologic malignancies
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Hematology and hematologic malignancies
Stephen V Desiderio
Temporal and Spatial Control of V(D)J Recombination
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Activation of Proto-Oncogenes by Chromosomal Translocation
Leukaemia
Hematology and hematologic malignancies
Genoveffa Franchini
T-Cell Transformation by Oncoviruses
Leukaemia
Hematology and hematologic malignancies
Christophe P Nicot
HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB
Leukaemia
Hematology and hematologic malignancies
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Hematology and hematologic malignancies
